SHANGHAI, March 23, 2026 /PRNewswire/ — Belief BioMed (“BBM”) and Grand Life Sciences Group Co., Ltd. (“Grand Life Sciences”) today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life Sciences the rights to commercialize its investigational product, BBM-H803, in Mainland China, Hong Kong China, Macau China, and Taiwan China. The collaboration underscores the shared commitment of both sides to leverage their respective strengths and resources in their respective fields, to accelerate the commercialization process of the product, help hemophilia A patients access innovative treatment option, and jointly promote the development of the gene therapy industry. The agreement was signed by Xiao Xiao, Co-founder, Chairman and CSO of Belief BioMed, and Zenghui, Feng, Chairman of Grand Life Sciences.

Dr. Xiao Xiao, Co-founder, Chairman and Chief Science Officer of Belief BioMed, said, “Belief BioMed focuses on the cutting-edge gene therapy field, with our product pipeline covering the rare and common diseases, striving to fill a large number of unmet clinical needs. In 2025, we successfully launched China’s first gene therapy for Hemophilia B, BBM-H901, providing a novel treatment option for patients in this field. Now, turning to the treatment of hemophilia A, we are delighted to forge this strategic partnership with Grand Life Sciences. By combining Belief BioMed’s solid clinical development expertise with Grand Life Sciences’ robust commercialization capabilities, we are creating a powerful synergy to jointly advance the commercialization of gene therapies for hemophilia A. We look forward to bringing this new treatment option to hemophilia A patients in China.”

Mr. Zenghui Feng, Chairman of Grand Life Sciences Group, said, “Leveraging our extensive blood product resources of its subsidiary, Grand Shuyang, and deep expertise in the field of hematology, this collaboration with Belief BioMed in hemophilia A represents a pivotal strategic move to build our innovative pipeline. We look forward to integrating Belief BioMed’s cutting-edge R&D capabilities with Grand Life Sciences’ mature commercialization platform and market channels. Together, we aim to efficiently accelerate the patient access to this innovative therapy in China. Our shared goal is to enable more hemophilia A patients to benefit earlier, relieving them from the physical burden of frequent injections and the fear of bleeding episodes.”

About Hemophilia A

Hemophilia A is a genetic disorder caused by the deficiency of factor Ⅷ, and it is characterized by reoccurring, spontaneous bleeding episodes within joints, muscles, and soft tissues. Reoccurring joints bleeding can result in joint deformity, and disability in severe cases. In China, the hemophilia prevalence rate stands between 2.73 and 3.09 per 100,000 people. There are over 30,000 registered cases of hemophilia A. Currently, most patients rely on factor Ⅷ as a replacement therapy, despite the risk of exposure to infection, together with inconvenience of administration. Furthermore, patients with hemophilia A face multiple challenges, including limited treatment options and a lack of standardized diagnostic and therapeutic procedures. Consequently, there is a pressing unmet need for better medical care among these patients. ^[3]

About BBM-H803

BBM-H803 is an AAV-based gene therapy with independent intellectual property rights owned by Belief BioMed. It is administered intravenously to deliver the coagulation factor Ⅷ gene into the body of patients with hemophilia A, thereby improving and maintaining the coagulation factor level in the patient’s body for a long time, for the prevention of bleeding. BBM-H803 uses liver-tropic capsid and highly efficient gene expression cassette, and the drug production uses the company’s independently developed serum-free suspension culture process, which meets the requirements of the Good Manufacturing Practice for Pharmaceuticals.

Since 2022, the Investigator Initiated Trial (IIT, NCT05454774) of BBM-H803 has been on-going, and in December of the same year, BBM-H803 was granted Orphan Drug Designation (ODD) by the U.S. FDA. In July 2023, the Investigational New Drug (IND) application for BBM-H803 was approved by China NMPA. In October 2024, the drug received Rare Pediatric Disease Designation (RPDD) from the U.S. FDA.

Driven by deep mutual trust and seamless collaboration, this partnership will accelerate the commercialization of Belief BioMed’s hemophilia A gene therapies in China. It promises to bring new hope to patients while fueling the continued growth of China’s gene therapy sector.

Reference

About Belief BioMed

Belief BioMed Inc. (BBM) is a global biotech company that integrates the research and development, manufacturing and clinical application of gene therapy products. The company is committed to providing innovative and more effective gene therapies for severe genetic and chronic diseases through safe and efficient viral vector technology. BBM has developed hundreds of key vector technologies, including HEK293 cell suspension serum-free culture process and full-scale chromatography purification process, and has established a commercial production platform for gene therapy drugs. The company has been building up its capabilities in a variety of fields including novel AAV capsids targeting different tissues, efficient transgene expression cassette design, and advanced clinically applicable vector manufacturing process. It has also established an extensive R&D pipeline covering a wide range of unmet clinical needs in different therapeutic areas such as hemophilia, DMD, Parkinson’s disease, osteoarthritis, etc. Several product pipelines have entered clinical studies or submitted IND filings. The Biologics License Application (BLA) of a gene therapy for the treatment of adult patients with hemophilia B, has been approved in Mainland China and Macao China.

For more information, please visit: https://www.beliefbiomed.com/. 

About Grand Life Sciences

Headquartered in Changping District, Beijing, Grand Life Sciences is an international pharmaceutical and healthcare enterprise group driven by innovation and supported by a solid industrial foundation. After years of development, the Group has built a diversified industrial layout covering five sectors: blood products, probiotics, vaccines, medical nutrition, and perioperative care. Grand Life Sciences closely tracks cutting-edge technologies in global drug discovery and development. Guided by clinical value and forward-looking strategic planning, the company has built a distinctive product portfolio and a differentiated pipeline covering the entire R&D lifecycle. Grand Life Sciences maintains industry-leading positions across multiple fields, including blood products, live biotherapeutic products, perioperative hemostasis, and vaccines, and currently has more than 30 core innovative product pipelines. The company has established five R&D centers in Beijing, Chengdu, Nanjing, Wuhan, and Hangzhou. To date, more than 30 products are in clinical development, continuously injecting new momentum into the company’s innovation-driven growth. Grand Life Sciences has built high-standard manufacturing bases with advanced quality management systems in nearly ten cities across China. Its sales network covers all provinces and municipalities nationwide, reaching hundreds of thousands of terminal outlets. Blood products are sold globally, with cumulative exports to more than 20 countries, and the company continues to accelerate its expansion into international markets. With the mission of “serving the people wholeheartedly,” Grand Life Sciences consistently upholds the business philosophy of “patient- and consumer-centered, research-based, and market-oriented development.” Guided by the belief that “one dose of medicine can save two lives,” the company actively fulfills its corporate social responsibilities and is committed to building a globally innovative enterprise in the life sciences sector.

Statement

This information is only for the purpose of introducing the company’s news, events and information on that date, and is not intended to promote any company’s products and/or services, nor should it be construed as providing any advice or recommendation on the selection of any drugs, medical devices and treatment options.

For information about any company products, diseases and/or treatments, please consult a healthcare professional.

BBM-H803 described herein has not been approved for marketing.

PROVIDENCIALES, Turks and Caicos Islands, March 23, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, officially made its debut at Tomorrowland Winter, bringing its “Guided into the Future” campaign to life through immersive on-site activations in Alpe d’Huez.

The opening day featured KuCoin’s visual festival presence across the mountain, the appearance of the 12 KuCoin Guardians, and the opening of KuCoin Base Point in the Main Festival Area. Together, these experiences brought KuCoin’s brand philosophy into the live festival setting and created new ways for festivalgoers to engage with the brand.

Marking the first major live activation under KuCoin’s global partnership with Tomorrowland, this also reflected the broader values behind the collaboration: community, creativity, and trust. Through music, culture, and immersive storytelling, KuCoin and Tomorrowland brought a shared vision of connection and trust to life for a global audience.

About KuCoin

Founded in 2017, KuCoin is a leading global crypto platform trusted by over 40 million users across 200+ countries and regions. The platform delivers innovative digital-asset services, offering access to 1,000+ listed tokens, spot and futures trading, institutional wealth management, and a Web3 wallet.

Recognized by Forbes and Hurun, KuCoin holds SOC 2 Type II and ISO 27001:2022 certifications, underscoring its commitment to top-tier security. KuCoin continues expanding its regulated footprint under CEO BC Wong, building a reliable and trusted digital-asset ecosystem.

Learn more: www.kucoin.com

NEW DELHI, March 23, 2026 /PRNewswire/ — MiTAC Computing Technology Corporation, a global leader in high-performance and energy-efficient server solutions, and a subsidiary of MiTAC Holdings Corporation (TWSE:3706), is showcasing the latest AI-optimized compute and GPU servers at Convergence India (Booth B3-28), spearheading the development of efficient and sustainable future data centers.

Featured products include three GPU servers G8825Z5, G4520G6, NVIDIA MGX™ architecture server, and enterprise-level R2520G6 – all built for modular, scalable data center deployments.

G‑Series | High‑Density AI & HPC Platforms for Large‑Scale Compute

G8825Z5 supports up to eight AMD Instinct™ MI325X/MI350X GPUs and dual AMD EPYC™ 9005 processors, delivering exceptional compute density and bandwidth for large‑scale AI model training.

G4520G6 is powered by dual Intel® Xeon® 6 processors and supports up to eight PCIe Gen5 GPUs and MRDIMM memory, offering massive parallel throughput for generative AI, data analytics, and HPC applications.

The third demo product is based on NVIDIA MGX™ architecture 4U platform with 8 GPUs powered by dual Intel® Xeon® 6700P and supports up to eight NVIDIA H200 NVL or NVIDIA RTX PRO 6000 Blackwell GPUs, integrating NVIDIA BlueField‑3 DPU and high‑bandwidth networking for AI cluster performance. Ideal for large‑scale training and inference.

R‑Series | Enterprise Compute with Balanced Flexibility

R2520G6 features dual Intel® Xeon® 6 processors, up to 32 DDR5‑6400 RDIMMs, and scalable NVMe U.2 support—including configurations with up to 24 drives—the R2520G6 delivers reliable bandwidth and long‑term performance stability for data storage, big data analytics, and AI data preprocessing.

“India represents one of the most dynamic and fast-evolving data center markets in the world as well as one of MiTAC Computing’s focus markets. We are proudly bringing MiTAC’s global innovation and trusted quality closer to local customers in India.”

— Stephanie Chen, Director of APAC Sales, MiTAC Computing Technology Corporation

Visit MiTAC Computing at Booth B3-28 (Hall 3) to experience its latest server and cluster solutions firsthand.

For more information, visit:

– AMD Platform Brochure

– Intel Platform Brochure

– NVIDIA Platform Brochure

About MiTAC Computing

MiTAC Computing delivers comprehensive, energy-efficient server solutions backed by industry expertise dating back to the 1990s. Specializing in AI, HPC, cloud, and edge computing, MiTAC Computing employs rigorous methodologies to ensure uncompromising quality—across barebones, systems, racks, and cluster levels—achieving performance and integration. This commitment to quality at every level sets MiTAC Computing apart.

With a worldwide presence and end-to-end capabilities—from R&D and manufacturing to global support—MiTAC Computing provides agile, customized platforms for hyperscale data centers, HPC, and AI applications, ensuring optimal performance and scalability to meet unique business needs. Leveraging the latest advancements in AI and liquid cooling, and unifying the MiTAC brand with Intel DSG and TYAN server products, MiTAC Computing stands out for its innovative, efficient, and reliable server technology and its hardware and software integrated solutions—empowering businesses to meet future challenges.

Visit https://www.mitaccomputing.com/

SHANGHAI, March 23, 2026 /PRNewswire/ — JinkoSolar, the global leading PV and ESS supplier, has globally launched its new AIDC modules for data centers. Built on the proven Tiger Neo 3.0 TOPCon platform technology, this product is specifically designed for conventional data centers, AI data centers, GPU clusters, supercomputing plants, edge computing network centers, chip plants, AI factories, and AI-powered carbon-neutral IDZ,etc. AIDC module addresses the specially high requirements of data centers, including high load capacity, high asset security, prolonged non-stop operation, extreme weather resistance, super stability and reliability, low O&M requirements, and large-scale deployment, providing the best possible clean energy solution for “computing-power synergy” in the AI world.

 The six core advantages of this module:

1. High Efficiency and High Power Output: Minimizing LCOE
   Based on JinkoSolar’s patent Tiger Neo 3.0 technology platform, combines current mature mass production capabilities with future-oriented technological scalability, delivering a front-side efficiency of 24.8% or higher and a power output of 670W or higher. Given the same space, it can generate more electricity for data centers, effectively improving roof and land utilization, and minimizing LCOE over the entire lifecycle
2. High Bifacial Efficiency:  Provides More Extra Free Power
   Thanks to the inherent advantage of TOPCon cells’ symmetrical and complete front-and-back structure, combined with Jinko’s MAX technology, the Tiger Neo 3. 0 platform modules achieve a bifaciality of 85% ± 5%. Compared to the limitation of BC modules—where power generation is concentrated on the back, resulting in a bifaciality of only 65%–75%—the Neo 3.0’s rear-side power generation capacity approaches that of the front side. Since modules are priced based on their front-side rated power, the power generated from the back effectively provides “free computing capacity expansion” for AI data centers: taking a 670W module with an 85% bifaciality ratio as an example, under ground reflectance conditions of 0.26, the total output power can reach 844W. For every 1W of front-side power cost paid by the user, they actually obtain 1.26W of total power generation capacity. This characteristic is particularly significant in high-latitude cold regions and desert environments—such as the Gobi Desert—which are preferred locations for AI data centers. The high reflectivity of snow and sand provides a natural boost to “free power.”
3. High-to-Low Irradiance Response: Unlocking All-Weather Power Generation Potential
   Data centers have a smooth power load curve and demand extremely high power supply stability, yet early mornings, evenings, and overcast or rainy weather are precisely the periods when PV power generation is weakest. JinkoSolar’s data center modules inherit the excellent low-light response characteristics of the Flying Tiger 3 platform and have been specifically optimized for low-irradiance conditions. In the low-irradiance range of 100–200 W/m² (typical light intensity during overcast or rainy days, or at dawn and dusk), power generation during morning and evening hours can be increased by up to 8.93% compared to BC modules. Even in extreme low-light scenarios such as dense fog or building shading, their relative power output remains stable at 95%–98%. The system’s equivalent generation duration is significantly extended, and the power generation curve better aligns with data centers’ long-term, round-the-clock, stable, and smooth power consumption needs, effectively increasing the proportion of self-consumed green electricity and improving grid compatibility. In regions with significant peak-to-off-peak price differentials, this further enhances project returns and reduces pressure on the power grid.
4. High Fire Resistance Rating: Building an Ultimate Safety Barrier
   Safety is the lifeline of a data center. To meet the highest standards for electrical fire prevention, JinkoSolar has adopted the dual certification of the photovoltaic industry’s most stringent IEC 61730-2:2023 standard and UL 790 Class A as its core requirements. These standards mandate that flame spread be ≤1.82 meters and that the module withstand a 30cm × 30cm glowing wood block without burning through, elevating the module’s fire resistance and flame retardancy to a new level. Critical insulation materials meet the highest UL 94 V-0 flame-retardant rating, self-extinguishing within 10 seconds after the flame is removed, with no burning droplets. All critical insulation materials in the assembly have passed rigorous needle flame and glowing wire tests under the IEC 60695 standard, ensuring they will not become a source of ignition under extreme conditions. Additionally, the assembly employs a patented arc-resistant junction box and connection technology, fundamentally reducing the risk of DC arcing and providing high-standard safety protection for data center rooftops.
5. Superior Hail Resistance: Confidently Withstands Extreme Weather
   As critical information infrastructure, data centers must ensure absolute reliability under any severe weather conditions. The new product has successfully passed a 55-millimeter hail impact test—a size comparable to a tennis ball, far exceeding the conventional 25-millimeter test standard for standard modules. High-strength tempered glass and a shock-absorbing encapsulation structure not only withstand instantaneous physical impacts but also break the risk chain of “mechanical damage → electrical failure → fire hazard” at its source.
6. Ultra-High Mechanical Load Capacity: Building a Robust Physical Safety Barrier
   Beyond rigorous hail resistance, the modules possess exceptional mechanical load-bearing capacity. The product has passed tests with 6,000 Pa of front-side load and 4,000 Pa of rear-side load, capable of withstanding snow pressure exceeding 600 kilograms per square meter. Even under extreme snow load conditions, the weight of accumulated snow will not cause the modules to rupture or expose internal circuits. In typhoon-prone regions, the modules remain firmly secured to the roof even under strong winds, eliminating secondary risks such as encapsulation material cracking or junction box loosening caused by structural deformation, thereby ensuring structural integrity and electrical safety during extreme weather.

JinkoSolar’s data center modules leverage six core technologies—extreme efficiency, high bifaciality, high/low irradiance response, high fire resistance, hail resistance, and high mechanical load capacity—to truly deliver “more efficient, more stable, and safer” green power for the computing era. As a global leader in cumulative PV shipments, JinkoSolar remains driven by technological innovation and deeply committed to specialized application scenarios. This launch not only marks JinkoSolar’s successful exploration of the limits of product performance in complex scenarios but also represents another significant milestone in the company’s efforts to support the energy transition across all industries.

SINGAPORE, March 23, 2026 /PRNewswire/ — Digital travel platform Agoda unveils a selection of weekend trip destinations across Asia, perfect for travelers seeking a quick escape. In today’s fast-paced world, weekend trips have become increasingly appealing as they offer a refreshing break from the daily grind without requiring extensive time off work. These short getaways provide an opportunity to explore new cultures, indulge in local cuisines, and experience diverse landscapes, all within a few days.

Whether it’s a serene beach retreat, a bustling city adventure, or a cultural exploration, weekend trips cater to the modern traveler’s desire for spontaneity and variety, making them ideal for those looking to recharge and rejuvenate.

Siem Reap, Cambodia – Siem Reap stands as a gateway to the ancient world, with the iconic Angkor Wat and other historic temples like Ta Prohm and Bayon Temple. Beyond its archaeological wonders, the city offers vibrant nightlife on Pub Street and cultural immersion through local markets and museums. Ideal for history enthusiasts, Siem Reap presents to visitors both exploration and relaxation.

Goa, India – Known for its lively beaches and vibrant culture, Goa is a haven for those looking to unwind and enjoy a festive atmosphere. From the scenic Dudhsagar Falls to the historic Fort Aguada, Goa offers a combination of natural beauty and cultural landmarks. Visitors can indulge in local seafood, explore quaint villages, and experience the region’s unique blend of Indian and Portuguese influences.

Hoi An, Vietnam – Hoi An captivates with its well-preserved architecture and charming canals. This former port city is a cultural treasure, featuring wooden Chinese shophouses and French colonial buildings. Visitors can enjoy the Hoi An Night Market, relax on An Bang Beach, or take a basket boat tour on the Thu Bon River, making it a perfect destination for cultural exploration.

Kuala Lumpur, Malaysia – Kuala Lumpur is a vibrant city that offers a mix of cultural immersion and modern attractions. From the iconic Petronas Twin Towers to the bustling Petaling Street, visitors can explore a variety of experiences. The city’s rich culinary scene and diverse cultural heritage make it an exciting destination for a weekend getaway.

Busan, South Korea – Busan is a lively port city known for its beaches, mountains, and cultural sites. Visitors can explore the scenic Gwangalli Beach, visit the historic Beomeosa Temple, or enjoy the vibrant atmosphere of Jagalchi Market. With its blend of natural beauty and urban excitement, Busan is perfect for a dynamic weekend escape.

Koh Samui, Thailand – Koh Samui is a tropical paradise known for its stunning beaches and luxurious resorts. Visitors can unwind at Chaweng Beach, explore the Samui Elephant Sanctuary, or take in the views from Lad Koh Viewpoint. With its harmonious blend of relaxation and adventure, Koh Samui is perfect for beach lovers seeking a serene escape.

Andrew Smith, Senior Vice President, Supply at Agoda shared, “Asia is a treasure trove of experiences, and Agoda is thrilled to guide travelers to these incredible destinations. Whether you’re seeking cultural immersion, beach relaxation, or urban exploration, Agoda has the perfect weekend getaway for you.”

With over 6 million holiday properties, more than 130,000 flight routes, and over 300,000 activities, Agoda offers travelers the flexibility to create their ideal weekend escape. For the best deals, visit Agoda’s website or download the Agoda mobile app.